We established a xenograft containing both normal and leukemic cells (mixed human T-cell depleted bone marrow (nBM) and an AML primary sample) in NSG mice (competitive xenograft nBM/AML2; Fig. 4a) as described20,29. Here, RUNX3 is linked to acute myeloid leukemia.